Accelerating radiopharmaceutical breakthroughs with high-sensitivity and high-resolution SPECT scanners for transformative research
Imaging the Future of Medicine
Our
Story
About Us
MH3D Inc. is a medical device company developing next-generation SPECT imaging systems with unmatched sensitivity and accuracy. Our flagship technology focuses on an ultrahigh-sensitivity SPECT system designed to revolutionize the early detection and monitoring of cancer, cardiovascular, and neurodegenerative diseases.
Our History
MH3D’s roots are deeply embedded in academic excellence and industry expertise. Our technology is the culmination of over two decades of pioneering research in nuclear imaging detectors from the University of Michigan and the University of Illinois, seamlessly integrated with 20 years of real-world application in the medical imaging industry.
Our Mission
At MH3D, we are committed to pushing the boundaries of medical imaging to enhance diagnostic precision, empower clinicians, and improve patient outcomes worldwide.
Our startup is founded on a vision to revolutionize early detection of cancer, neurological disorders, and cardiovascular diseases through our pioneering nuclear imaging technology. We're committed to supporting pre-clinical and clinical research and enhancing current standards of care with high-precision tools designed for early diagnosis.
Our Product
Alpha-SPECT™ Mini
Introducing the MH3D Alpha-SPECT™ Mini, the world's first CZT-based pre-clinical SPECT system, offering features unmatched by current market options:
-
Unparalleled energy resolution is perfect for multi-isotope imaging.
-
An ultra-wide stationary field of view is needed for comprehensive whole-body dynamic studies of small animals.
-
Fully stationary detector system coupled to a dual-FOV micro-scanning aperture for optimized imaging resolution and ultrahigh sensitivity for a wide range of imaging applications.
-
Fully optimized multi-isotope imaging capability for studying alpha-labeled radiopharmaceuticals (alpha-RPT).
Configuration | A | - | AA |
|---|---|---|---|
Mode | Standard Mode (A) | High Resolution Mode (A) | High-Resolution Mode (AA) |
Field of View (W x L) | 60mm x 80mm | 40mm x 60mm | 30mm x 60mm |
Spatial Resolution at 140 keV | < 2.5mm | <1.5mm | < 1mm |
Sensitivity | 4200 cps/MBq | 600 cps/MBq | Customizable |
Energy Resolution at 140 keV | 3-4 keV | 3-4 keV | 3-4 keV |
Detector | CZT | CZT | CZT |
Bore Size | 12cm | 12cm | Customizable |
Reconstruction Algorithm | OSEM | OSEM | OSEM |
Meet the Team
Chairman
Dr. Zhong He, PhD
Dr. Zhong He, Professor in the Department of Nuclear Engineering and Radiological Sciences at the University of Michigan, pioneered the groundbreaking 3D-readout technique, a cornerstone of semiconductor gamma-ray imaging detectors. This innovation enables exceptional energy resolution and unmatched sensitivity, transforming nuclear imaging technology.
Chief Clinical Officer
Dr. Aileen Ouyang, PhD
Dr. Aileen Ouyang has 9 years of combined academic and industrial experience in the medical device industry. She earned her PhD in Biomedical Engineering from the University of Michigan, Ann Arbor, specializing in clinical affairs and regulatory processes.
.jpg)
Senior Software Engineer
Brendan Deleon, MS
Brendan holds a master's degree in Computer Science from the University of Urbana-Champaign. He specializes in imaging processing, data processing, full-stack software development, demonstrating his expertise across multiple technical domains. a strong foundation in computer science. Brendan is committed to delivering innovative solutions that drive projects to success.
CEO
Xiaopei Huang, MBA
Xiaopei Huang, CEO of MH3D, holds a Master of Science in Electrical Engineering from the University of Michigan and an Executive MBA from Lawrence Technological University. With a proven leadership and strategic expertise track record, she spearheads MH3D's mission to drive groundbreaking medical innovations, blending technical proficiency with visionary business acumen.
Director of Applied Research/RSO
Dr. Jack Kuchta, PhD
Dr. Kuchta earned his PhD in Nuclear Engineering and Radiological Sciences from the University of Michigan, Ann Arbor. His team is focused on creating next-generation clinical SPECT systems to enhance clinical workflows and improve patient care outcomes.
.jpg)
Software Engineer
David Paylan, MS
David is a dedicated Data Scientist who holds a Master's degree from Hopkins University. With a specialization in imaging processing and analytics, he is committed to developing software products that enhance patient outcomes. His professional expertise contributes to the advancement innovative solutions in SPECT technology.
CTO
Dr. Ling Jian Meng, PhD
Dr. Ling-Jian Meng, Professor in the Department of Nuclear, Plasma, and Radiological Engineering at the University of Illinois at Urbana-Champaign (UIUC). His research centers on advancing emission tomography imaging technologies, focusing on revolutionizing the diagnosis and monitoring of cancer, cardiovascular diseases, and neurological disorders.
.jpg)
Head of Engineering
Ansong Qin
Ansong has over 30 years of experience in software development, data processing, imaging algorithms, and production-ready system engineering. As Head of Engineering, he leads the technical development of next-generation SPECT imaging platforms.
Upcoming Events
European Molecular Imaging Meeting 2026
Ljubljana, Slovenia
Mar 24 - 27, 2026
Industry
Participation
Preclinical Imaging Consortium
Philadelphia, Pennsylvania
Apr 13 - 15, 2026
Industry Participation
Supported By
